Article
Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mice.
Science China. Life sciences - 1 Oct 2016
Chen Xiaoqing, Zhang Wuchang, Wang Qian, Du Lili, Yi Yi, Liu Yan, Liu Xu, Duan Shengzhong
Abstract excerpt
The purpose of the present study was to study the impacts of eplerenone (EPL), an antagonist of mineralocorticoid receptors (MR), on atrial fibrosis in a mouse model with selective fibrosis in the atrium, and to explore the possible mechanisms. Using mutant TGF-β1 transgenic (Tx) mice, we first demonstrated that EPL inhibited atrial fibrosis specifically and decreased macrophage accumulation in the atria of these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
